Skip to main content

Study M245

Study name

Coupland NJ 2005

Title

Decreased prefrontal myo-inositol in major depressive disorder

Overall design

The aim of this study was to test whether major depressive disorder (MDD) patients would show reduced prefrontal/anterior cingulate cortex levels of myo-inositol. Nonmedicated moderate-severe MDD patients (depression group, n = 13) and matched control subjects were studied (control group, n = 13). Proton magnetic resonance spectroscopy stimulated echo acquisition mode spectra (3.0 T; echo time = 168 msec; mixing time = 28 msec; repetition time = 3000 msec) were obtained from prefrontal/anterior cingulate cortex. Metabolite data were adjusted for tissue composition. Metabolite quantification was reported relative to total creatine as the reference peak.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Depression; Depression;

Criteria for depression

DSM-IV diagnosed MDD

Sample size

26

Tissue

Central; Brain; Anterior cingulate cortex/Prefrontal cortex;

Platform

MRS; MRS: 3.0-T scanner (Magnex Scientific, Abingdon, United Kingdom/Surrey Medical Imaging Systems, Guilford, United Kingdom);

PMID

15953489

DOI

10.1016/j.biopsych.2005.02.027

Citation

Coupland NJ, Ogilvie CJ, Hegadoren KM, et al. Decreased prefrontal myo-inositol in major depressive disorder. Biol Psychiatry 2005;57(12):1526-34.

Metabolite

myo-Inositol/(Creatine and Phosphocreatine) ratio;